STL Volume 19 Number 4

3 POSTS 0 COMMENTS
Purchase PDF for $2.79
Update on Drugs and Drug News

Update on Drugs and Drug News: July-August 2014

Update on drugs Metronidazole 1.3% vaginal gel (Actavis plc), Ecallantide for SC injection (Kalbitor®), Dalbavancin for IV injection (Dalvance™), Taliglucerase alfa for IV injection (Elelyso™), and Efinaconazole 10% topical solution (Jublia®)
Review of Evidence for Dietary Influences on Atopic Dermatitis

Review of Evidence for Dietary Influences on Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory skin disease affecting children and adolescents worldwide. This articles reviews the potential relationship of atopic dermatitis to diet and the effectiveness of elimination diets and diet supplementation in the management of AD.
Sirolimus: A Therapeutic Advance

Sirolimus: A Therapeutic Advance for Dermatologic Disease

Sirolimus, also known as rapamycin (SRL, Rapamune®), was approved in 1999 by the US Food and Drug Administration to prevent graft rejection in renal transplantation. This articles reviews Sirolimus, its pharmacokinetics, mechanism of action, and indication.

POPULAR

Advertisement